Post-market Follow Up Study on Paragon CRT® 100 (Paflufocon D)

Recruiting N/A Interventional Study
Myopia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
8 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
250 (estimated)
Sponsor
CooperVision International Limited (CVIL) · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The main objective of this post market clinical study is to evaluate the effectiveness and safety of the Paragon CRT®100 Contact Lens.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Patient contact lens refraction should fit within the available parameters of the study lenses (spherical power within -4.00D and the cylinder power within 1.50D). 2. Is willing to comply with the wear and visit schedule. 3. Is willing to participate and signed the informed c…
Contacts

Jose Vega, OD, MSc

9256402964

jvega2@coopervision.com

CONTACT